Incorporated in 2010, Translumina is an interventional cardiovascular device company that delivers world-class products and services. Starting with direct imports and assembling of components, we are now a fully integrated product development and manufacturing company with facilities in Germany and India.
$70M sweet spot round size
2010
$70M
from 1 investors over 1 rounds
Translumina Therapeutics raised $70M on September 27, 2019
Investors: Everstone